J&J Wins 1st Trial Victory In Levaquin MDL

Law360, New York (June 20, 2011, 1:04 PM EDT) -- A Minnesota federal jury on Friday handed Johnson & Johnson its first trial victory in a multidistrict litigation that claims the antibiotic Levaquin causes serious tendon injuries, saying the pharmaceutical giant adequately warned patients about the drug's risks.

The jury sided against Calvin Christensen, a Minnesota man who said he suffered an Achilles tendon rupture just days after taking Levaquin. The verdict comes about six months after a separate jury told J&J unit Ortho-McNeil-Janssen Pharmaceuticals Inc. to pay $1.8 million to another Levaquin user in the...
To view the full article, register now.

Related

Sections

Case Information

Case Title

In Re: Levaquin Products Liability Litigation


Case Number

0:08-md-01943

Court

Minnesota

Nature of Suit

Personal Inj. Prod. Liability

Judge

John R. Tunheim

Date Filed

June 16, 2008


Case Title

Christensen et al v. Johnson & Johnson et al


Case Number

0:07-cv-03960

Court

Minnesota

Nature of Suit

Personal Inj. Prod. Liability

Judge

John R. Tunheim

Date Filed

September 12, 2007

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.